YOLFTbeta
ICON PLC

ICON PLC

ICLR · NASDAQ · Healthcare / Diagnostics & Research

194.65USD-5.86 (-2.92%)

Price History

Full chart

Market Stats

Previous Close200.51
Open200.56
Day Range194.39 – 200.56
52-Week Range66.57 – 214.94
Volume966.50K
Market Cap14.12B
P/E (TTM)194.66
Forward P/E16.53
EPS0.94
Dividend Yield0.00%
Beta1.24
50-Day Avg169.42
200-Day Avg145.34

About

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Barry Balfe
  • Employees40.20K
  • HeadquartersSouth County Business Park, Dublin, Ireland, D18 X5R3, USA
  • Websitehttps://www.iconplc.com

Leadership

  • Mr. Barry BalfeCEO & Director · b. 1979
  • Dr. John Climax Ph.D.Founder & Independent Non-Executive Director · b. 1953
  • Mr. Nigel Clerkin A.C.A.Chief Financial Officer · b. 1974
  • Mr. Steve EmpolitiChief Commercial Officer
  • Lyons EmerChief Accounting Officer
  • Mr. Thomas N. O'LearyChief Information Officer
  • Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company Secretary · b. 1975
  • Ms. Niamh MurphyDirector of Corporate Communications
  • Mr. David GreenVice President of Marketing
  • Mr. Joe CroninChief Human Resources Officer

Financials

Income Statement

Currency: USD1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue42.10M55.80M80.77M116.16M156.56M225.72M225.72M296.92M346.20M455.60M630.72M865.25M887.61M900.04M945.73M1.12B1.34B1.50B1.57B1.67B1.76B2.60B2.81B2.80B5.48B7.74B8.12B8.28B8.25B
Growth (%)-+32.54%+44.74%+43.82%+34.77%+44.18%0.00%+31.54%+16.60%+31.60%+38.44%+37.18%+2.58%+1.40%+5.08%+17.90%+19.83%+12.52%+4.77%+5.81%+5.52%+47.62%+8.09%-0.30%+95.93%+41.24%+4.89%+1.99%-0.37%
Cost of Revenue-29.30M42.04M63.80M83.37M122.37M122.37M162.56M220.02M256.26M354.48M489.24M507.78M541.39M611.92M718.13M845.41M903.17M908.98M961.33M1.03B1.83B1.97B1.99B3.97B5.53B5.72B5.85B6.08B
Gross Profit42.10M26.50M38.72M52.36M73.18M103.35M103.35M134.36M126.18M199.33M276.24M376.01M379.83M358.66M333.81M396.87M490.64M600.15M666.00M705.15M726.96M769.49M831.70M808.03M1.51B2.21B2.40B2.44B2.18B
Gross Margin100.00%47.49%47.94%45.08%46.75%45.79%45.79%45.25%36.45%43.75%43.80%43.46%42.79%39.85%35.30%35.59%36.72%39.92%42.29%42.31%41.34%29.64%29.64%28.89%27.52%28.60%29.56%29.42%26.37%
Operating Expense019.52M30.57M41.29M54.97M78.42M78.42M99.98M106.37M151.52M207.00M276.51M272.38M266.56M294.55M324.45M369.48M397.80M384.46M393.46M388.63M396.13M398.30M416.53M1.13B1.42B1.44B1.34B1.16B
Operating Income42.10M6.98M8.15M11.08M18.21M24.93M24.93M34.38M19.80M47.82M69.24M99.50M107.45M92.09M39.26M72.42M121.17M202.35M281.54M311.69M338.34M373.36M433.41M391.50M378.53M795.24M956.15M1.10B1.01B
Operating Margin100.00%12.51%10.09%9.53%11.63%11.04%11.04%11.58%5.72%10.50%10.98%11.50%12.11%10.23%4.15%6.50%9.07%13.46%17.88%18.70%19.24%14.38%15.45%14.00%6.91%10.27%11.78%13.26%12.27%
EBITDA42.10M9.01M11.38M16.05M24.23M32.23M32.23M44.98M28.07M62.77M88.25M130.11M140.86M127.73M69.32M111.09M168.67M263.69M339.21M379.43M401.98M451.76M501.81M488.83M694.09M1.37B1.52B1.56B823.57M
EBITDA Margin100.00%16.14%14.08%13.82%15.48%14.28%14.28%15.15%8.11%13.78%13.99%15.04%15.87%14.19%7.33%9.96%12.62%17.54%21.54%22.77%22.86%17.40%17.88%17.48%12.66%17.66%18.74%18.88%9.98%
Net Income3.90M8.05M6.07M10.98M14.20M18.28M18.28M25.74M12.72M38.30M55.96M78.12M94.30M87.07M22.88M55.42M102.81M172.47M239.54M262.18M281.49M322.82M373.99M327.81M153.19M505.30M612.34M791.47M229.34M
Net Income Margin9.26%14.43%7.51%9.45%9.07%8.10%8.10%8.67%3.67%8.41%8.87%9.03%10.62%9.67%2.42%4.97%7.70%11.47%15.21%15.73%16.01%12.44%13.33%11.72%2.79%6.53%7.54%9.56%2.78%
Interest Expense02.60M575.00K2.51M1.07M318.00K318.00K202.00K37.71K125.00K1.40M4.11M3.53M1.13M1.64M1.95M1.29M785.00K3.99M13.01M12.63M13.50M13.28M13.02M182.42M229.73M336.70M237.24M188.11M
Interest Expense % of Total Revenue0.00%4.66%0.71%2.16%0.68%0.14%0.14%0.07%0.01%0.03%0.22%0.47%0.40%0.13%0.17%0.17%0.10%0.05%0.25%0.78%0.72%0.52%0.47%0.47%3.33%2.97%4.15%2.86%2.28%

Balance Sheet

Currency: USD1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-93.80M100.12M110.87M148.32M235.01M186.92M335.32M349.07M476.34M693.14M867.28M908.40M949.54M1.04B1.20B1.44B1.53B1.72B1.83B2.19B2.39B2.91B3.44B17.39B17.19B16.99B16.88B16.27B
Total Liabilities-23.50M23.07M31.03M51.97M98.10M68.46M118.56M106.61M172.48M303.43M410.92M336.15M279.54M353.92M447.53M531.88M577.59M954.71M880.67M955.62M999.97M1.29B1.59B9.32B8.69B7.75B7.35B7.08B
Total Equity-71.63M77.05M79.72M96.35M136.91M118.46M216.76M241.56M302.74M388.40M456.37M572.25M670.00M681.54M754.58M910.58M950.21M764.20M945.17M1.23B1.39B1.62B1.85B8.07B8.50B9.24B9.52B9.19B
Cash-12.00M26.55M11.89M39.70M18.31M25.26M55.68M59.51M63.04M76.88M58.38M144.80M255.71M119.24M114.05M182.52M118.90M103.91M192.54M282.86M395.85M520.31M840.30M752.21M288.77M378.10M538.78M647.29M
Total Debt-4.10M2.77M4.00M11.37M7.13M8.69M17.44M3.17M5.16M94.88M106.18M325.00K158.00K----587.21M547.93M605.74M684.46M454.55M433.61M5.65B4.83B3.94B3.60B3.56B
Net Debt--8.40M-23.78M-7.89M-28.32M-11.19M-16.57M-55.68M-54.50M-57.88M18.00M47.80M-144.50M-255.51M-119.24M-114.05M-182.52M-118.90M246.09M155.97M66.03M-46.59M-65.76M-406.69M4.89B4.54B3.56B3.06B2.91B

Cash Flow

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.50M8.40M-1.57M17.27M21.48M21.48M43.64M13.78M50.45M42.97M81.28M255.07M87.43M20.19M113.77M221.23M169.95M279.53M259.20M383.08M264.01M412.54M594.72M829.14M563.32M1.16B1.29B1.04B
Investing Cash Flow-45.30M7.66M-22.57M4.81M--35.28M-47.34M-16.28M-55.30M-118.47M-117.45M-65.69M14.58M-152.38M-121.11M-184.38M-112.32M-204.77M-74.81M-177.81M-37.30M-162.03M-46.58M-6.02B-145.87M-226.65M-266.79M-187.53M
Financing Cash Flow2.20M-1.43M9.56M2.72M-4.63M-4.63M42.52M6.62M7.70M93.96M22.34M-105.06M15.30M-3.85M-1.58M28.80M-116.40M-81.39M-93.71M-119.28M-108.40M-125.41M-235.02M5.11B-864.17M-844.04M-837.18M-771.26M
Capital Expenditure9.40M7.51M6.69M10.43M52.66M52.66M13.10M12.13M31.52M75.39M67.88M33.79M30.95M35.28M30.79M29.49M32.78M49.73M42.60M28.00K48.40M50.65M51.05M93.75M142.16M140.69M168.06M174.21M
Free Cash Flow-7.90M892.00K-8.26M6.84M-31.18M-31.18M30.55M1.65M18.94M-32.42M13.40M221.28M56.48M-15.09M82.98M191.74M137.17M229.80M216.60M48.71M215.62M361.90M543.67M735.39M421.15M1.02B1.12B861.99M
Dividends Paid----------------------13.19M-35.83M---
FCF to OCF-526.67%10.62%526.05%39.63%-145.11%-145.11%69.99%11.99%37.53%-75.47%16.49%86.75%64.60%-74.75%72.94%86.67%80.71%82.21%83.56%12.72%81.67%87.72%91.42%88.69%74.76%87.88%86.94%83.19%
Dividend Paid to FCF----------------------2.43%-8.51%---

Earnings

Report DateSep 30, 1998Oct 1, 1998Mar 30, 1999Jul 28, 1999Jan 11, 2000Apr 4, 2000Sep 26, 2000Oct 9, 2000Jan 16, 2001May 31, 2001Sep 25, 2001Nov 30, 2001Mar 26, 2002May 31, 2002Jul 30, 2002Oct 8, 2002Mar 31, 2003May 31, 2003Sep 30, 2003Nov 30, 2003Jan 13, 2004Apr 1, 2004Jul 27, 2004Nov 30, 2004Mar 30, 2005Aug 2, 2005Jan 10, 2006Apr 28, 2006Jul 26, 2006Oct 27, 2006Feb 13, 2007Apr 24, 2007Jul 26, 2007Oct 23, 2007Feb 21, 2008Apr 29, 2008Jul 22, 2008Oct 21, 2008Feb 23, 2009Apr 28, 2009Jul 22, 2009Oct 21, 2009Feb 25, 2010Apr 27, 2010Jul 27, 2010Oct 21, 2010Feb 24, 2011Apr 21, 2011Jul 20, 2011Oct 27, 2011Feb 16, 2012Apr 24, 2012Jul 24, 2012Nov 1, 2012Feb 19, 2013Apr 25, 2013Jul 25, 2013Oct 24, 2013Feb 20, 2014Apr 30, 2014Jul 30, 2014Oct 22, 2014Feb 25, 2015Apr 28, 2015Jul 28, 2015Oct 27, 2015Feb 23, 2016Apr 26, 2016Jul 26, 2016Oct 20, 2016Feb 16, 2017Apr 27, 2017Jul 27, 2017Oct 26, 2017Feb 15, 2018May 2, 2018Jul 25, 2018Oct 24, 2018Feb 20, 2019May 1, 2019Jul 24, 2019Oct 23, 2019Feb 19, 2020Apr 22, 2020Jul 22, 2020Oct 21, 2020Feb 24, 2021Apr 28, 2021Jul 21, 2021Nov 3, 2021Feb 22, 2022Apr 27, 2022Jul 27, 2022Nov 2, 2022Feb 22, 2023Apr 26, 2023Jul 26, 2023Oct 25, 2023Mar 12, 2024Apr 24, 2024Jul 24, 2024Oct 23, 2024Feb 19, 2025Apr 30, 2025Jul 23, 2025Oct 22, 2025Feb 25, 2026Jun 23, 2026Jul 29, 2026Oct 27, 2026Oct 28, 2026
EPS Estimate0.040.040.040.030.040.050.050.050.06-0.07-0.07-0.070.070.09-0.10-0.110.110.12-0.090.100.120.120.140.200.220.200.220.230.250.270.290.420.340.340.340.340.380.370.370.370.360.210.220.020.080.150.220.270.330.340.380.400.450.500.580.700.760.820.891.011.101.111.141.181.261.281.301.321.421.421.481.541.601.601.681.741.831.701.101.541.831.972.112.462.622.692.792.943.052.873.083.283.443.413.673.843.433.093.183.283.312.162.262.402.44
EPS Actual0.040.040.050.040.040.050.050.050.060.080.070.070.070.080.080.070.100.080.110.110.110.120.130.100.090.110.120.130.180.180.200.210.230.250.270.280.310.350.350.350.380.400.400.370.380.440.360.210.210.020.070.150.210.290.340.360.430.450.530.570.640.790.870.860.951.021.111.121.141.191.261.291.311.351.431.421.511.541.621.631.691.741.831.701.201.721.902.062.122.552.632.762.863.003.132.903.113.303.463.473.753.353.433.193.263.312.522.222.352.46-
Surprise0.00%0.00%25.00%33.33%0.00%0.00%0.00%0.00%0.00%-0.00%-0.00%-14.29%0.00%11.11%-10.00%-0.00%9.09%8.33%-0.00%10.00%0.00%8.33%28.57%-10.00%-9.09%5.00%4.55%8.70%8.00%3.70%6.90%-16.67%2.94%2.94%11.76%17.65%5.26%0.00%2.70%18.92%0.00%0.00%-4.55%0.00%-12.50%0.00%-4.55%7.41%3.03%5.88%13.16%12.50%17.78%14.00%10.34%12.86%14.47%4.88%6.74%0.99%0.91%0.90%0.00%0.85%0.00%0.78%0.77%2.27%0.70%0.00%2.03%0.00%1.25%1.88%0.60%0.00%0.00%0.00%9.09%11.69%3.83%4.57%0.47%3.66%0.38%2.60%2.51%2.04%2.62%1.05%0.97%0.61%0.58%1.76%2.18%-12.76%0.14%3.24%2.52%0.91%-23.87%2.78%3.98%2.50%-
Timing------Pre-market-Pre-market---Pre-market--Pre-marketPre-market-Pre-market-Pre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours--After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap14.12B
Enterprise Value16.74B
Trailing P/E194.66
Forward P/E16.53
PEG Ratio0.56
Price / Sales1.70
Price / Book1.51
EPS0.94
Book Value121.55
Revenue (TTM)8.29B
Gross Profit (TTM)1.98B
EBITDA523.48M
Profit Margin0.33%
Operating Margin9.41%
Return on Equity0.29%
Return on Assets0.97%
Shares Outstanding77.15M
Shares Float77.10M
Beta1.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 18 analystsTarget 188.24
  • Strong Buy
    9
  • Buy
    1
  • Hold
    7
  • Sell
    1

Ownership Breakdown

Institutions
107.79%
Insiders
0.45%
Retail / Other
0.00%

Top Institutional Holders

  • Artisan Partners Limited Partnership
    8.64M11.19%
  • Wellington Management Company LLP
    5.32M6.90%
  • FMR Inc
    5.27M6.83%
  • Amvescap Plc.
    5.26M6.82%
  • Harris Associates L.P.
    4.47M5.79%
  • Brave Warrior Advisors LLC
    3.15M4.09%
  • Greenhaven Associates Inc
    3.10M4.02%
  • Principal Financial Group Inc
    2.95M3.82%
  • Massachusetts Financial Services Company
    2.11M2.73%
  • Ruane, Cunniff & Goldfarb L.P.
    2.05M2.65%
  • Boston Partners Global Investors, Inc
    1.62M2.10%
  • Trinity Street Asset Management LLP
    1.49M1.93%
  • AllianceBernstein L.P.
    1.38M1.79%
  • D. E. Shaw & Co LP
    1.36M1.76%
  • Dimensional Fund Advisors, Inc.
    1.27M1.65%
  • Earnest Partners LLC
    1.24M1.61%

Top Fund Holders

  • Artisan International Value Investor
    6.74M8.74%
  • Oakmark Select Investor
    2.73M3.54%
  • Vanguard Health Care Inv
    1.26M1.63%
  • Ninety One GSF Glb Frchs I Acc USD
    1.25M1.62%

Stock Splits

  • Aug 13, 20082:1
  • Oct 24, 20062:1